MISOPROSTOL INDUCTION OF LABOR IN MULTIPARA PREGNANT WOMEN: A MINI-SURVEY FOR PREDICTORS OF OUTCOME.
Journal Title: International Journal of Advanced Research (IJAR) - Year 2018, Vol 6, Issue 4
Abstract
Objectives: To evaluate dose-related outcome of induction of labor (IOL) using misoprostol vaginal inserts (MVI) in multipara pregnant women so as to determine the appropriate dose for getting trial success defined as having vaginal delivery (VD) within 24-hr induction-to-delivery (ITD) interval. Patients & Methods: 644 pregnant women underwent clinical evaluation and vaginal examination to determine Bishop score using the Simplified Bishop Score (SBS). All women received 25 ?g MVI only once and were monitored for labor progress as judged by SBS and uterine contractions with fetal heart monitoring. In absence of fetal distress manifestations and membranes were still intact, but uterine contractions occurred <3 times/10 minutes, another MVI was used for a maximum of 6 doses. Uterine contraction augmentation was provided as amniotomy or/and oxytocin infusion started 4-hrs after the last MVI was placed. Study outcomes included trail success rate, number of MVI used, frequency and mode of augmentation and delivery assistance. Results: 530 women (82.3%) had VD; 159 women without augmentation, 182 women had amniotomy, 105 women received oxytocin drip and 84 women required both. Only 168 women (26.1%) had instrumentally-assisted VD. Mean ITD interval was 10.9?6.3 hr; 492 women had ITD interval <24 hr for a trial success rate of 76.4%. Cesarean section was indicted in 114 women (17.7%). Only 29 women received four, 71 three, 93 two, while 451 women received one MVI, VD rate was significantly (p<0.00001) lower among women received higher number of MVI. Statistical analyses defined high MVI dose and BMI as negative, while high parity is a positive significant predictor for trial success. High MVI dose and BMI are positive, while high SBS and high parity are negative significant predictors for long ITD interval. Kaplan-Meier regression analysis defined the appropriate MVI for IOL trial success at a mean dose of 1.5?0.039 (95% CI: 1.4-1.55). Conclusion: MVI is a satisfactory modality for IOL trial in multipara pregnant women with VD rate of 82.3% and ITD interval of <24-hr in 76.4%. Lower BMI and higher number of previous VD indicate higher possibility of trial success. SBS is appropriate for women selection for trial and follow-up and can predict outcome if combined with BMI, parity and number of MVI used.
Authors and Affiliations
Ayman A. Shedid, Hesham M. Abo Ragab.
Keywords
Related Articles
- EP ID EP290422
- DOI 10.21474/IJAR01/6941
- Views 77
- Downloads 0
SKY YOGA AND DEER EXERCISE FOR GYNAECOLOGICAL PROBLEMS IN ADOLESCENT GIRLS.
Introduction: The institutionalized children lack adequate opportunities to form enduring emotional relationships, which are basic to the adaptation of an individual?s personal and social needs. As a result, their basic...
ISOLATION, SCREENING AND IDENTIFICATION OF BIOSURFACTANT PRODUCING FUNGAL STRAINS.
Biosurfactants are the surface active compounds which are of microbial origin that are produced by different strains of bacteria fungi and actinomycetes. Soil samples were collected and 10 fungal colonies were isolated u...
ASSESSMENT OF KNOWLEDGE AND ATTITUDE ON PALLIATIVE CARE AMONG NURSING OFFICERS AT TERTIARY CARE CENTRE OF SOUTH INDIA.
It is estimated in India the total number of people who need palliative care is likely to be 5.4 million people a year.The nurse is a key member of health team who typically has the greatest contact with the patient. Thi...
PROGNOSTIC VALUE OF THE EXPRESSION OF ENDOGENOUS HYPOXIA ASSOCIATED PROTEINS HYPOXIA INDUCIBLE FACTOR-1 ALPHA (HIF-1) AND CARBONIC ANHYDRASE ISOFORM 9 (CAIX) EXPRESSIONS IN BREAST CARCINOMA.
Background: hypoxia has been found to be related to malignant initiation, progression, increasing the occurrence of metastasis and therapy resistance in many cancer types, which made a real need for discovering drugs tha...
ANTIMICROBIAL RESISTANCE PATTERN AMONG NON-FERMENTING GRAM NEGATIVE BACILLI ISOLATED FROM CLINICAL SAMPLES IN A TERTIARY CARE HOSPITAL IN INDIA.
Background: Non-fermenting gram negative bacilli have emerged as important pathogens and their isolation is increasing among hospital acquired infections. Many are innately resistant to most antibiotics and often multidr...